HARVARD BIOSCIENCE, INC. Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current
HARVARD BIOSCIENCE, INC. (HBIO) had Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current of $1.74 million as of 2017-12-31, per its 10-K filed 2019-03-18.
Discontinued › Notes › Discontinued Operations and Disposal Groups › Disposal Group, Including Discontinued Operation, Liabilities, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent · last filed 2019-03-18
- 2017-12-31: Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current $1.74M.
| Period end | Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2017-12-31 | $1.74M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |